Sensitivity analysis results: Cost (in 2021 USD) per additional diagnosed infection, by strategy and proportion of pregnant persons screened for HCV, compared with anti-HCV with reflex to HCV RNA testing at 18 months among infants with known exposure, United States, 2022. As a higher proportion of pregnant persons were screened, the cost per additional diagnosed infection increased in the two universal testing scenarios.